A study of the human immune response to Lolium perenne (rye) pollen and its components, LoL p I and LoL p II (rye I and rye II). I. Prevalence of reactivity to the allergens and correlations among skin test, IgE antibody, and IgG antibody data

In a stratified random sample of 320 white adults, the prevalence of puncture skin test positivity (ST +) to Lolium perenne (rye grass)-pollen extract (LPE) was 16%. Fifteen percent of all subjects (or 84% of subjects classified LPE IgE antibody positive [Ab +]) was classified IgE Ab + to highly pur...

Full description

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 78; no. 6; pp. 1190 - 1201
Main Authors Freidhoff, L.R, Ehrlich-Kautzky, E, Grant, J.H, Meyers, D.A, Marsh, D.G
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier 01.12.1986
Subjects
Online AccessGet full text
ISSN0091-6749
DOI10.1016/0091-6749(86)90271-X

Cover

Abstract In a stratified random sample of 320 white adults, the prevalence of puncture skin test positivity (ST +) to Lolium perenne (rye grass)-pollen extract (LPE) was 16%. Fifteen percent of all subjects (or 84% of subjects classified LPE IgE antibody positive [Ab +]) was classified IgE Ab + to highly purified Lol p I (Rye I), and 4% of all subjects (or 26% of subjects classified LPE IgE Ab +) was classified IgE Ab + to highly purified Lol p II (Rye II). These data and similar results obtained in an allergy-enriched group of 361 subjects are consistent with previous studies that Lol I is a major allergen and Lol II is a minor allergen of LPE. Whether we studied LPE, Lol I, or Lol II, responder subjects were younger than nonresponder subjects and more male than female subjects were responders. We then investigated the quantitative interrelationships among ST, IgE, and IgG Ab responsiveness to LPE, Lol I, and Lol II in the allergy-enriched group. For each allergen, log-log correlations were strong and significant for ST versus IgE Ab and for IgE Ab versus IgG Ab. All subjects IgE Ab + to Lol I or Lol II were IgG Ab + to that allergen, supporting other evidence for a commonality in the genetic control influencing the production of IgE and IgG Abs to a given allergen. Log-log correlations among ST end points, IgE Ab levels, or IgG Ab levels were strong for LPE versus either Lol I or Lol II but weak between Lol I and Lol II, consistent with the reported lack of cross-reactivity between Lol I and Lol II. Despite these findings, almost all Lol II + subjects were Lol I + by ST (98%), IgE Ab (91%), and IgG Ab (83%), suggesting that the Ia-restricted immune recognition of both these molecules is at least in part under a common genetic control.
AbstractList In a stratified random sample of 320 white adults, the prevalence of puncture skin test positivity (ST+) to Lolium perenne (rye grass)-pollen extract (LPE) was 16%. Fifteen percent of all subjects (or 84% of subjects classified LPE IgE antibody positive (Ab+)) was classified IgE Ab+ to highly purified Lol p I (Rye I), and 4% of all subjects (or 26% of subjects classified LPE IgE Ab+) was classified IgE Ab+ to highly purified Lol p II (Rye II). Despite the findings, almost all Lol II+ subjects were Lol I+ by ST (98%), IgE Ab (91%), and IgG Ab (83%), suggesting that the Ia-restricted immune recognition of both these molecules is at least in part under a common genetic control.
The authors investigated the quantitative interrelationships among ST, IgE, and IgG Ab responsiveness to LPE, Lol I, and Lol II in the allergy-enriched group. Almost all Lol II+ subjects were Lol I+ by ST (98%), IgE Ab (91%), and IgG Ab (83%), suggesting that the Ia-restricted immune recognition of both these molecules is at least in part under a common genetic control.
In a stratified random sample of 320 white adults, the prevalence of puncture skin test positivity (ST +) to Lolium perenne (rye grass)-pollen extract (LPE) was 16%. Fifteen percent of all subjects (or 84% of subjects classified LPE IgE antibody positive [Ab +]) was classified IgE Ab + to highly purified Lol p I (Rye I), and 4% of all subjects (or 26% of subjects classified LPE IgE Ab +) was classified IgE Ab + to highly purified Lol p II (Rye II). These data and similar results obtained in an allergy-enriched group of 361 subjects are consistent with previous studies that Lol I is a major allergen and Lol II is a minor allergen of LPE. Whether we studied LPE, Lol I, or Lol II, responder subjects were younger than nonresponder subjects and more male than female subjects were responders. We then investigated the quantitative interrelationships among ST, IgE, and IgG Ab responsiveness to LPE, Lol I, and Lol II in the allergy-enriched group. For each allergen, log-log correlations were strong and significant for ST versus IgE Ab and for IgE Ab versus IgG Ab. All subjects IgE Ab + to Lol I or Lol II were IgG Ab + to that allergen, supporting other evidence for a commonality in the genetic control influencing the production of IgE and IgG Abs to a given allergen. Log-log correlations among ST end points, IgE Ab levels, or IgG Ab levels were strong for LPE versus either Lol I or Lol II but weak between Lol I and Lol II, consistent with the reported lack of cross-reactivity between Lol I and Lol II. Despite these findings, almost all Lol II + subjects were Lol I + by ST (98%), IgE Ab (91%), and IgG Ab (83%), suggesting that the Ia-restricted immune recognition of both these molecules is at least in part under a common genetic control.
In a stratified random sample of 320 white adults, the prevalence of puncture skin test positivity (ST +) to Lolium perenne (rye grass)-pollen extract (LPE) was 16%. Fifteen percent of all subjects (or 84% of subjects classified LPE IgE antibody positive [Ab +]) was classified IgE Ab + to highly purified Lol p I (Rye I), and 4% of all subjects (or 26% of subjects classified LPE IgE Ab +) was classified IgE Ab + to highly purified Lol p II (Rye II). These data and similar results obtained in an allergy-enriched group of 361 subjects are consistent with previous studies that Lol I is a major allergen and Lol II is a minor allergen of LPE. Whether we studied LPE, Lol I, or Lol II, responder subjects were younger than nonresponder subjects and more male than female subjects were responders. We then investigated the quantitative interrelationships among ST, IgE, and IgG Ab responsiveness to LPE, Lol I, and Lol II in the allergy-enriched group. For each allergen, log-log correlations were strong and significant for ST versus IgE Ab and for IgE Ab versus IgG Ab. All subjects IgE Ab + to Lol I or Lol II were IgG Ab + to that allergen, supporting other evidence for a commonality in the genetic control influencing the production of IgE and IgG Abs to a given allergen. Log-log correlations among ST end points, IgE Ab levels, or IgG Ab levels were strong for LPE versus either Lol I or Lol II but weak between Lol I and Lol II, consistent with the reported lack of cross-reactivity between Lol I and Lol II. Despite these findings, almost all Lol II + subjects were Lol I + by ST (98%), IgE Ab (91%), and IgG Ab (83%), suggesting that the Ia-restricted immune recognition of both these molecules is at least in part under a common genetic control.In a stratified random sample of 320 white adults, the prevalence of puncture skin test positivity (ST +) to Lolium perenne (rye grass)-pollen extract (LPE) was 16%. Fifteen percent of all subjects (or 84% of subjects classified LPE IgE antibody positive [Ab +]) was classified IgE Ab + to highly purified Lol p I (Rye I), and 4% of all subjects (or 26% of subjects classified LPE IgE Ab +) was classified IgE Ab + to highly purified Lol p II (Rye II). These data and similar results obtained in an allergy-enriched group of 361 subjects are consistent with previous studies that Lol I is a major allergen and Lol II is a minor allergen of LPE. Whether we studied LPE, Lol I, or Lol II, responder subjects were younger than nonresponder subjects and more male than female subjects were responders. We then investigated the quantitative interrelationships among ST, IgE, and IgG Ab responsiveness to LPE, Lol I, and Lol II in the allergy-enriched group. For each allergen, log-log correlations were strong and significant for ST versus IgE Ab and for IgE Ab versus IgG Ab. All subjects IgE Ab + to Lol I or Lol II were IgG Ab + to that allergen, supporting other evidence for a commonality in the genetic control influencing the production of IgE and IgG Abs to a given allergen. Log-log correlations among ST end points, IgE Ab levels, or IgG Ab levels were strong for LPE versus either Lol I or Lol II but weak between Lol I and Lol II, consistent with the reported lack of cross-reactivity between Lol I and Lol II. Despite these findings, almost all Lol II + subjects were Lol I + by ST (98%), IgE Ab (91%), and IgG Ab (83%), suggesting that the Ia-restricted immune recognition of both these molecules is at least in part under a common genetic control.
Author Grant, J.H
Marsh, D.G
Ehrlich-Kautzky, E
Freidhoff, L.R
Meyers, D.A
Author_xml – sequence: 1
  fullname: Freidhoff, L.R
– sequence: 2
  fullname: Ehrlich-Kautzky, E
– sequence: 3
  fullname: Grant, J.H
– sequence: 4
  fullname: Meyers, D.A
– sequence: 5
  fullname: Marsh, D.G
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=8039746$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/3782681$$D View this record in MEDLINE/PubMed
BookMark eNqNks9uEzEQxn0oKm3gBRBIPiDUSEnwv117j1VVykqRQIJK3CLHO5sadu2t7a2U5-YFcNJVruXk8ff9ZuY7zCU6c94BQu8pWVFCy8-EVHRZSlFdqXJeESbp8tcZujjJr9FljL9J_nNVnaNzLhUrFb1Af69xTGOzx77F6QHww9hrh23fjw5wgDh4FwEnj9e-s2OPBwjgsnUV9jDHg-86cFi7BtsUsfF95sGluMj8Gg-4PnpTXR-7Ju1Y1fMVrlf4e4AnnQcZOMQIoE2yTzbtD3sPoXTeEnbg4rHT-BCg08n6g9B7t8Pxj3U4QUwLXO9uM5Xs1jf7xZGvd3cnBTc66TfoVau7CG-nd4buv9z-vPm6XH-7q2-u18uWlSwtGa-UNLQpRaOVkYS1BRG8kGAKyitDt0UrCddKUMLAtFBWrVCK6GbbyK3mhs_Qp-e5Q_CPY0636W000HXagR_jRkoqJSnVi6CoZClZIV8EqSgrJiT_H5AJluPP0IcJHLc9NJsh2F6H_WY6kOx_nHwdje7aoJ2x8YQpwispyoy9e8Za7Td6FzJy_0NJJgtR8X9M0dKq
CODEN JACIBY
ContentType Journal Article
Copyright 1987 INIST-CNRS
Copyright_xml – notice: 1987 INIST-CNRS
DBID FBQ
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
7S9
L.6
7X8
DOI 10.1016/0091-6749(86)90271-X
DatabaseName AGRIS
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Immunology Abstracts
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts
AIDS and Cancer Research Abstracts
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EndPage 1201
ExternalDocumentID 3782681
8039746
US8727549
Genre Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: AI-19727
– fundername: NIAID NIH HHS
  grantid: AI-20059
GroupedDBID ---
--K
--M
-~X
.1-
.55
.FO
.GJ
.XZ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
354
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8F7
8FE
8FH
8P~
9JM
AAAJQ
AABNK
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAXKI
AAXUO
ABBQC
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACPRK
ACRLP
ACRPL
ADBBV
ADEZE
ADFRT
ADMUD
ADNMO
ADVLN
AEBSH
AEIPS
AEKER
AENEX
AFFNX
AFJKZ
AFRAH
AFRHN
AFTJW
AFXIZ
AGEKW
AGHFR
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIKHN
AITUG
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
C45
CAG
CJTIS
COF
CS3
DU5
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FBQ
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDU
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
LK8
LUGTX
M27
M41
MO0
N4W
N9A
O-L
O9-
O9~
OAUVE
OBH
ODZKP
OHH
OHT
OK0
OK1
OVD
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
R2-
RIG
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SJN
SPCBC
SSH
SSI
SSZ
T5K
TEORI
TWZ
UGJ
UNMZH
UV1
WH7
WOW
WUQ
X7M
XFW
YOC
YQI
YQJ
Z5R
ZGI
ZXP
ZY1
~02
~G-
~KM
IQODW
3V.
7RV
7X7
8C1
AFKRA
AFKWA
AJOXV
AMFUW
BBNVY
BENPR
BHPHI
CGR
CUY
CVF
ECM
EIF
HCIFZ
M2O
M7P
NPM
PKN
7T5
AAFWJ
ADXHL
AGCQF
AGQPQ
H94
7S9
L.6
7X8
ID FETCH-LOGICAL-f262t-23987c1d64da8c702f504357ec5139c1b5f703a84102ecfe69f4880adbd7ba3c3
ISSN 0091-6749
IngestDate Fri Jul 11 05:46:12 EDT 2025
Fri Jul 11 09:30:04 EDT 2025
Fri Jul 11 06:54:11 EDT 2025
Fri Jul 11 07:12:32 EDT 2025
Wed Feb 19 02:36:23 EST 2025
Wed Apr 02 07:24:25 EDT 2025
Thu Apr 03 09:44:55 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Human
Monocotyledones
Immune response
IgE
Sex
IgG
Skin sensitizing antibody
Extract
Blocking antibody
Immunochemistry
Atopy
Immunogenetics
Gramineae
Angiospermae
Plant origin
Spermatophyta
Pollen
Lolium perenne
Age
Allergen
Skin test
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-f262t-23987c1d64da8c702f504357ec5139c1b5f703a84102ecfe69f4880adbd7ba3c3
Notes F01
8727549
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 3782681
PQID 14624270
PQPubID 23462
PageCount 12
ParticipantIDs proquest_miscellaneous_77177068
proquest_miscellaneous_49767257
proquest_miscellaneous_14692473
proquest_miscellaneous_14624270
pubmed_primary_3782681
pascalfrancis_primary_8039746
fao_agris_US8727549
PublicationCentury 1900
PublicationDate 1986-Dec
PublicationDateYYYYMMDD 1986-12-01
PublicationDate_xml – month: 12
  year: 1986
  text: 1986-Dec
PublicationDecade 1980
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
PublicationTitle Journal of allergy and clinical immunology
PublicationTitleAlternate J Allergy Clin Immunol
PublicationYear 1986
Publisher Elsevier
Publisher_xml – name: Elsevier
SSID ssj0009389
Score 1.556716
Snippet In a stratified random sample of 320 white adults, the prevalence of puncture skin test positivity (ST +) to Lolium perenne (rye grass)-pollen extract (LPE)...
In a stratified random sample of 320 white adults, the prevalence of puncture skin test positivity (ST+) to Lolium perenne (rye grass)-pollen extract (LPE) was...
The authors investigated the quantitative interrelationships among ST, IgE, and IgG Ab responsiveness to LPE, Lol I, and Lol II in the allergy-enriched group....
SourceID proquest
pubmed
pascalfrancis
fao
SourceType Aggregation Database
Index Database
Publisher
StartPage 1190
SubjectTerms Adult
ALERGENOS
ALLERGENE
ALLERGENS
Allergic diseases
analysis
ANTIBODIES
Antibody Formation
ANTICORPS
ANTICUERPOS
Biological and medical sciences
Dialysis
ENSAYO
Female
General aspects
GENERO HUMANO
GENRE HUMAIN
Humans
Hypersensitivity
Hypersensitivity - immunology
IMMUNE RESPONSE
Immunoglobulin E
Immunoglobulin E - analysis
Immunoglobulin G
Immunoglobulin G - analysis
IMMUNOGLOBULINE
IMMUNOGLOBULINS
immunology
Immunopathology
INMUNOGLOBULINA
LOLIUM PERENNE
Male
MANKIND
Medical sciences
Middle Aged
PEAU
PIEL (ANIMAL)
Plant Extracts
Plant Extracts - analysis
POLEN
POLLEN
Pollen - immunology
REPONSE IMMUNITAIRE
RESPUESTA INMUNOLOGICA
SKIN
Skin Tests
TESTAGE
TESTING
Title A study of the human immune response to Lolium perenne (rye) pollen and its components, LoL p I and LoL p II (rye I and rye II). I. Prevalence of reactivity to the allergens and correlations among skin test, IgE antibody, and IgG antibody data
URI https://www.ncbi.nlm.nih.gov/pubmed/3782681
https://www.proquest.com/docview/14624270
https://www.proquest.com/docview/14692473
https://www.proquest.com/docview/49767257
https://www.proquest.com/docview/77177068
Volume 78
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELb6kBAXBIWKAIU5cGiVboj3ZS_iErVJs6QtVWhF2ku0z6oCslWTHOBv8weYsb27aWl5XSLLa6_tzHw7Y3sejL1O44DLtsishEdty41jz4pF6llOFqRZ7OZOnNI55MGh3z9x34-80dLyuwWrpfksbiXfb_Ur-R-qYh3Slbxk_4Gy1UuxAstIX_xFCuPvX9G4o6PDlvf8Ot_eBXl8UDIUZfyqMmPsF18u5l8pRDF9VtWpwTeKxkQpGlDqVBcIZF9eTLRpxQ71al42Q_WUykfNMDR9Ta0qhfgiOlcIW2TPgctT3wqcEqqjiclNYRRcyttCzp5T4013dVWZ4umkR9PPZHaZaT-U8LyL7WYXcaEFgbJcPt-r6prGr-425VqPpGNLVc6f6p-5do3QG3bD3f6HXk-tt1VbT3b7w_1wp28NkNJng9NrLht7w87hseL-Vu3acdA97Q6VGeRuy5wPp9q5UPo37FJKJ59FgRFwyxc6qmopMIRcAMbi159znfrUaBLc1u_-RUrpA5Pq3Ug5ukVDvcAW3BrVkrm0RrghsCszStlGbdL1l9mqLQQZKax2BsNPgzrotCP19s8MVLqOcv9NVbcp_S0zMKpXeVSQdXA0RarkOrPL3VsvpYIdP2QPDHmho4HwiC1lkzV278BYhzxmPzqg8ABFDshuoPAAGg9Q4gFmBWg8gMEDbCIfb4HGAiDHAGIBaixsU3u4hFA9o_IRhKHqZepUKdx6C2ELagzQNGoM0Lg0qQoDquciBkBhAAgDQBjYBkQAlNy-rdoj_1c1QPz_hJ30usfIqSapiZXbvj2zKN6mSHjqu2kkE9G2c4oh6Iks8XAzlvDYy1EIR9JFzT9L8swPcpKxURqnIo6cxFlnKxNc_lMGXLiRm3DuyJTi_tmBF3luIiXP_DyXrtdga0jPcXSO6sL45KPErYrnBg22cY2-40sd1mZsuKnBXpX0HqOoofvDaJIV8ymdEqBCL9q_bRHYrnDubuHi9kegmnB3C-RkIdq-bLB1zWzVBB3czfiSP_vDAp6z-zW2X7CV2dU828Cdwyx-aQDyE_BaFUg
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+study+of+the+human+immune+response+to+Lolium+perenne+%28Rye%29+pollen+and+its+components%2C+Lol+p+I+and+Lol+P+II+%28Rye+I+and+Rye+II%29%3A+I.+Prevalence+of+reactivity+to+the+allergens+and+correlations+among+skin+test%2C+IgE+antibody%2C+and+IgG+antibody+data&rft.jtitle=Journal+of+allergy+and+clinical+immunology&rft.au=FREIDHOFF%2C+L.+R&rft.au=EHRLICH-KAUTZKY%2C+E&rft.au=GRANT%2C+J.+H&rft.au=MEYERS%2C+D.+A&rft.date=1986-12-01&rft.pub=Elsevier&rft.issn=0091-6749&rft.volume=78&rft.issue=6&rft.spage=1190&rft.epage=1201&rft_id=info:doi/10.1016%2F0091-6749%2886%2990271-X&rft.externalDBID=n%2Fa&rft.externalDocID=8039746
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0091-6749&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0091-6749&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0091-6749&client=summon